Learn more

SCRAS

Overview
  • Total Patents
    1,406
About

SCRAS has a total of 1,406 patent applications. Its first patent ever was published in 1962. It filed its patents most often in United Kingdom, France and South Africa. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are ROCHE PALO ALTO LLC, MSD KK and ACETYLON PHARMACEUTICALS.

Patent filings per year

Chart showing SCRASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Esanu Andre 362
#2 Braquet Pierre 321
#3 Godfroid Jean-Jacques 92
#4 Broquet Colette 87
#5 Heymans Francoise 73
#6 Laurent Jean-Pierre 69
#7 Pierre Braquet 50
#8 Bonato Marc 47
#9 Beguin Alain 46
#10 Pirotzky Eduardo 44

Latest patents

Publication Filing date Title
FR2930776A1 NEW CATALYTIC SYSTEMS FOR THE (CO) POLYMERIZATION OF LACTONES BY CYCLE OPENING
FR2915747A1 TRI-AMINO-PYRIMIDINE DERIVATIVES AS CDC25 PHOSPHATASE INHIBITORS
FR2912059A1 USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE
FR2910327A1 USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR TREATING PAIN INDUCED BY THERAPEUTIC TREATMENTS OF AIDS VIRUS.
FR2907680A1 THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN IN THE TREATMENT OF PAIN INDUCED BY AT LEAST ONE ANTI-CANCER AGENT
FR2904318A1 PYRIMIDINONE DERIVATIVES AND THEIR USE AS A MEDICINAL PRODUCT
FR2902341A1 THERAPEUTIC USE SIMULTANEOUS, SEPARATE OR SPREAD IN THE TIME OF AT LEAST ONE BOTULINUM NEUROTOXIN, AND AT LEAST ONE OPIACEOUS DERIVATIVE
FR2902101A1 PEPTIDES WITH ANTI-PROLIFERATIVE ACTIVITY
FR2898357A1 AMIDINE DERIVATIVES AND THEIR APPLICATIONS AS A MEDICINAL PRODUCT
FR2896502A1 NOVEL METHOD OF SYNTHESIZING 1,4-MORPHOLIN-2,5-DIONES
RU2394607C2 Device for injecting implant in process of reverse injection operation
RU2288739C2 Pharmaceutical composition that inhibit vascular proliferation and method for their using
RU2283664C2 Botulinum toxin application for producing preparation usable for treating pathological articulation states like coxarthrosis, epicondylitis and rotation muscle cuff disorders
RU2380362C2 Derivatives of five-member heterocycles, method of production and use thereof as medicinal agents
RU2216343C2 Incapsulation of water-soluble peptides
US6602849B1 Cyclic somatostatin analogs
CZ20002340A3 Novel tetracyclic analogs of camptothecins, process of their preparation, their use as a medicament and pharmaceutical composition containing thereof
RU2217161C2 Method for treatment of viral hepatitis
TW589189B Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768345A1 PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF A VIRAL HEPATITIS